Methodology

All entries for: Tes Pharma S.r.l.

July 10, 2026

Tes Pharma S.r.l.

Orphan Drug Designation

prevention of delayed graft function after renal transplantation

Disease Area: Rare Diseases
Source
Scroll to Top